Summary
Carlos Araya is a scientist-turned-entrepreneur with 12 years of experience building cross-disciplinary teams that translate genomic and biophysical research into clinical-grade products. As CEO and cofounder of Stealth Biotech and previously Jungla (acquired by Invitae), he has led efforts to integrate cellular and computational modeling into scalable genetic testing platforms that serve millions of patients. His academic work—spanning a Ph.D. and postdoctoral research at University of Washington and Stanford—produced high-throughput methods (including early deep mutational scanning approaches) and large-scale functional maps of RNA and transcriptional networks. Carlos combines rigorous, metric-driven leadership with empathy, and brings a global perspective shaped by formative years in Costa Rica, Norway, Brazil, and the U.S. Outside the lab he pursues endurance and exploration in mountains, forests, rivers, and the ocean, a trait that mirrors his appetite for ambitious, long-horizon projects. Based in Palo Alto, he bridges deep technical expertise and operational leadership to drive measurable impact in life sciences and healthcare.
12 years of coding experience
9 years of employment as a software developer
Ph.D., Genome Sciences, Ph.D., Genome Sciences at University of Washington
B.S., Biotechnology, Summa Cum Laude, B.S., Biotechnology, Summa Cum Laude at Washington State University
Spanish, English, Portuguese, Norwegian